Gaining Insight on the INSIGHT Phase 3 Study
Dr. Neeta Somaiah, MD Anderson Cancer, Center will present “Gaining Insight on the INSIGHT Phase 3 Study” for the GIST community on April 11, 2024.
Progress in Precision Medicine for GIST Patients
These new data were presented by Dr. Sebastian Bauer and Dr. Breelyn A. Wilky during the 2023 January ASCO Plenary Series from the INTRIGUE Efficacy Results of ctDNA Analysis for GIST Patients.
Deciphera Announces New Results from Analysis from Intrigue Study
Deciphera issued a press release today sharing the results of an exploratory analysis of data using circulating tumor DNA (ctDNA) from the INTRIGUE Phase 3 clinical study of ripretinib and announcing plans to initiate INSIGHT.